The EV amounts evaluated with EV-specific marker protein levels, apoptosis-linked gene 2-interacting protein X (Alix), tumor susceptibility gene (TSG101), and syntenin, in the purified EV fractions were also synergistically increased by adiponectin and roxadustat (Fig. 2B). The gene discussed is SDCBP; the disease is neoplasm.